Last updated: July 19, 2023
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Overall Status: Active - Recruiting
Phase
N/A
Condition
Biliary Tract Cancer
Abdominal Cancer
Digestive System Neoplasms
Treatment
EUS-CDS
Clinical Study ID
NCT05595122
NL81840.029.22
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Radiographically (CT or EUS) distal malignant bile duct obstruction
- Histology or cytology proven malignancy of the primary tumour or metastasis; onsitecytology evaluation after EUS guided fine-needle sampling that is highly suspected ofa malignancy suffices
- Indication for biliary drainage; in case of a resectable tumour this should bediscussed during a clinical multidisciplinary meeting
- Written informed consent
Exclusion
Exclusion Criteria:
- Age < 18 year
- Surgically altered anatomy after previous gastric, periampullary or duodenal resection
- Cancer extending into the antrum or proximal duodenum
- Extensive liver metastases
- WHO performance score of 4 (in bed 100% of time)
- Uncorrectable coagulopathy, defined by INR>1.5 or platelets < 50 x 10^9/L*
- Clinically relevant gastric-outlet obstruction
- Unable to complete sign informed consent
- Inclusion is allowed after corrective treatment measures are taken, according tolocal protocol and treating physician.
Study Design
Total Participants: 25
Treatment Group(s): 1
Primary Treatment: EUS-CDS
Phase:
Study Start date:
December 02, 2022
Estimated Completion Date:
March 01, 2024
Connect with a study center
Amsterdam UMC location VUmc
Amsterdam, 1081HV
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.